SGLT2 inhibitors in cardiology: A therapeutic breakthrough

The current hype around SGLT2 inhibitors in the treatment of heart failure patients is more than justified, according to Prof. Martin Cowie

The current hype around SGLT2 inhibitors in the treatment of heart failure patients is more than justified, according to Prof. Cowie (Imperial College, London). In an interview, he explains why the diabetes drug is now being used in cardiology.